KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) Shares Outstanding (Weighted Average) (2016 - 2025)

Repligen (RGEN) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $56234.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 0.53% to $56234.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $56234.0, a 0.53% increase, with the full-year FY2025 number at $56234.0, up 0.53% from a year prior.
  • Shares Outstanding (Weighted Average) was $56234.0 for Q4 2025 at Repligen, up from $55937.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $56234.0 in Q4 2025 to a low of $54805.0 in Q1 2021.
  • A 5-year average of $55448.2 and a median of $55479.0 in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 4.68% in 2021; the steepest drop was 99.9% in 2021.
  • Repligen's Shares Outstanding (Weighted Average) stood at $55015.0 in 2021, then rose by 0.81% to $55460.0 in 2022, then rose by 0.47% to $55720.0 in 2023, then grew by 0.39% to $55937.0 in 2024, then rose by 0.53% to $56234.0 in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Shares Outstanding (Weighted Average) are $56234.0 (Q4 2025), $55937.0 (Q4 2024), and $55720.0 (Q4 2023).